Related Experiment Video
Updated: Jul 28, 2026

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
Published on: May 22, 2019
Association between percent decline in serum total homocysteine and risk of first stroke
Xiao Huang1, Youbao Li1, Ping Li1
1From the Department of Cardiology (X.H., P.L., H.B., X.C.), Second Affiliated Hospital, Nanchang University; Division of Nephrology (Y.L., B.W., F.F.H., X.Q.), Nanfang Hospital, Southern Medical University; National Clinical Research Center for Kidney Disease (Y.L., B.W., F.F.H., X.Q.); State Key Laboratory of Organ Failure Research (Y.L., B.W., F.F.H., X.Q.); Guangdong Provincial Institute of Nephrology (Y.L., B.W., F.F.H., X.Q.); Departments of Cardiology (J.L., Y.Z., Y. Huo), Pharmacy (Y. Cui), and Neurology (Y. Huang), Peking University First Hospital; Department of Cardiology (N.S.), Peking University People's Hospital, Beijing; Department of Hypertension (J.W.), The Shanghai Institute of Hypertension, Centre for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai; Departments of Neurology (M.H.) and Cardiology (D.Y.), First People's Hospital, Lianyungang; Institute for Biomedicine and School of Health Administration (G.T.), Anhui Medical University, Hefei; and Department of Cardiology (Y. Chen), Chinese PLA General Hospital, Beijing, China.
Insights
Reducing serum total homocysteine (tHcy) levels is linked to a lower risk of first stroke in Chinese adults. This finding suggests that tHcy reduction may indicate the effectiveness of folic acid in stroke prevention.
Area of Science:
- Cardiovascular Research
- Neurology
- Clinical Trials
Background:
- The China Stroke Primary Prevention Trial (CSPPT) investigated stroke prevention strategies.
- Serum total homocysteine (tHcy) is a potential risk factor for cardiovascular events.
- Understanding the impact of tHcy reduction on stroke risk is crucial for public health.
Purpose of the Study:
- To determine if changes in serum total homocysteine (tHcy) levels correlate with the risk of experiencing a first stroke.
- To analyze the association between the percentage decline in tHcy and stroke incidence within the CSPPT cohort.
Main Methods:
- Analysis of 16,867 participants from the CSPPT with baseline and exit tHcy measurements.
- Primary outcome: first-ever stroke. Secondary outcome: composite of cardiovascular events.
- Calculation of percent tHcy decline: [(baseline tHcy - exit tHcy)/baseline tHcy × 100].
Main Results:
- Participants with a first stroke showed a significantly lower percent decline in tHcy compared to those without stroke.
- A 20% reduction in tHcy was associated with a 7% decrease in stroke risk (HR 0.93).
- Greater tHcy reduction (tertiles 2-3) significantly lowered stroke risk, with benefits observed across various demographic and clinical subgroups.
Conclusions:
- A significant association exists between percent lowering of serum tHcy and reduced first stroke risk in Chinese adults with hypertension.
- Further confirmation may establish tHcy reduction as a valuable marker for folic acid treatment efficacy in stroke prevention.
Objective:
To examine whether a change in serum total homocysteine (tHcy) levels is associated with first stroke risk in a post hoc analysis of the China Stroke Primary Prevention Trial (CSPPT).
Methods:
We analyzed 16,867 participants of the CSPPT with tHcy measurements at both baseline and exit visits. The primary outcome was first stroke. The secondary outcome was a composite of cardiovascular events consisting of cardiovascular death, myocardial infarction, and stroke. The percent decline in tHcy was calculated as [(baseline tHcy - exit tHcy)/baseline tHcy × 100].
Results:
Over the median treatment duration of 4.5 years, participants who developed a first stroke had a significantly lower percent decline in tHcy (β = -5.7; 95% confidence interval [CI] -8.8 to -2.6) compared to their counterparts. A 20% tHcy decline was associated with a reduction in stroke risk of 7% (hazard ratio [HR] 0.93; 95% CI 0.90-0.97). When percent decline in tHcy was assessed as tertiles, a significantly lower stroke risk was found in those in tertiles 2-3 (HR 0.79; 95% CI 0.64-0.97) compared with participants in tertile 1. Similar results were observed for the composite of cardiovascular events. The beneficial effect associated with greater tHcy reduction was observed across strata for age, sex, treatment group (with vs without folic acid), MTHFR C677T genotypes, baseline tHcy and serum folate levels, and blood pressure control.
Conclusions:
Percent lowering in tHcy was significantly associated with a reduction in first stroke risk in Chinese adults with hypertension, and if further confirmed, may serve as a useful indicator for folic acid treatment efficacy on stroke prevention.
Clinicaltrialsgov Identifier:
NCT00794885.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis III: Management
Ischemic Stroke l: Introduction
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology

